Prestige Consumer Healthcare PBH Estimates

NYSE PBH
$48.70 -1.09 (-2.19%)
As of: Sep 9, 2026 · 3:59 PM EDT
Analyst Estimates

Prestige Consumer Healthcare Inc. Revenue Estimates

Periods 27
Next Period Q2 26
Consensus 342.65 M

Analysts expect Prestige Consumer Healthcare Inc. to report revenue of 342.65 M for Q2 26, against a range of 328.07 M to 357.22 M. The most recent reported quarter, Q1 26, came in at 265.71 M, a 1.8% miss against the 270.47 M consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 283.79 M290.32 M296.52 M249.53 M274.11 M283.44 M281.62 M265.71 M--------
High Estimate 317.26 M304.66 M299.03 M274.60 M282.84 M301.56 M303.63 M292.05 M357.22 M370.55 M357.69 M361.12 M380.74 M390.63 M431.25 M322.19 M
Low Estimate 279.24 M252.12 M249.25 M233.71 M252.01 M281.55 M262.74 M248.90 M328.07 M303.51 M297.56 M320.75 M312.41 M338.86 M353.22 M295.44 M
Consensus Estimate 298.25 M278.39 M274.14 M254.16 M267.42 M291.55 M283.18 M270.47 M342.65 M337.03 M327.63 M340.94 M346.57 M364.74 M392.24 M308.82 M
Analyst Estimates

Prestige Consumer Healthcare Inc. Earnings Per Share (EPS) Estimates

Periods 27
Next Period Q2 26
Consensus 1.14

Analysts expect Prestige Consumer Healthcare Inc. to report earnings per share of 1.14 for Q2 26, against a range of 1.03 to 1.25. The most recent reported quarter, Q1 26, came in at 0.98, a 4.3% beat against the 0.94 consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 1.091.221.320.951.071.141.230.98--------
High Estimate 1.241.221.381.111.011.221.511.031.251.431.321.201.221.331.581.20
Low Estimate 1.041.081.160.970.891.141.410.851.031.191.181.041.041.171.381.06
Consensus Estimate 1.141.151.271.040.951.181.460.941.141.311.251.121.131.251.481.13